Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity
The collaboration will accelerate the global development of LAE102, a novel Activin Receptor Type 2 A (ActRII A ) Antagonistic Monoclonal Antibody (mAb) for muscle-preserving weight loss in Obesity LOS ANGELES, Nov. 20, 2024 /PRNewswire/ -- Laekna,...
Odoo S.A. announces a €500 million transaction, increasing the Belgian Unicorn's valuation to €5 billion
LOUVAIN-LA-NEUVE, Belgium, Nov. 20, 2024 /PRNewswire/ -- Odoo S.A., a leading provider of integrated business software, today announced a €500 million transaction led by CapitalG and Sequoia Capital, with participation from BlackRock, Mubadala...
Nature's Miracle Holding Inc. Announces $2.0 Million Debt to Equity Conversion by Management and Related Debt Holders
ONTARIO, Calif., Nov. 20, 2024 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, announced today that the Company's management team and...
TurtleTree Announces Formal Partnership with Singapore-Based Future-Focused CPG Company MAD Foods; Launching Coffee Line with LF+ Mid-Year 2025
MAD Foods and TurtleTree to bring ready-to-drink coffee beverage line to market with vegan-certified lactoferrin to provide key health benefits to consumers SACRAMENTO, Calif. and SINGAPORE, Nov. 20, 2024 /PRNewswire/ -- TurtleTree, a local leader...
Yatsen Announces Third Quarter 2024 Financial Results
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on November 20, 2024 GUANGZHOU, China, Nov. 20, 2024 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its...
